SCARB1 and cardiovascular disorder: They concluded that therapeutic interventions that inhibit the endothelial delivery of LDL into the arterial vials mediated by SRB-1 and DOCK 4 may be a potential remedy against the development of atherosclerosis and cardiovascular disease.